Starling Oncology, Inc.: Form 8-K (Item 1.05) filed with the SEC on 2026-05-22

An official record: a company's own disclosure to the U.S. Securities and Exchange Commission of a material cybersecurity incident (Form 8-K, Item 1.05). It is not ransomware attribution, and this page does not connect it to anything else on this site.

Notice

From US SEC EDGAR, Form 8-K Item 1.05 (Material Cybersecurity Incidents). Dataset version ref-09468761677a, updated 2026-05-22T20:30:17.000Z.

Filer (as EDGAR lists it today)
Starling Oncology, Inc.
Form
8-K
Items listed
1.05, 9.01
Filed
2026-05-22
Accepted by EDGAR
2026-05-22T20:30:17.000Z
Accession number
0001079973-26-000721
CIK
0001799191

Search this site for this name: Starling Oncology, Inc.. A matching name is not evidence that two records concern the same organisation or the same event.

Read on 2026-11-03T07:24:44.475Z under licence sec-website-dissemination@33178053 from https://data.sec.gov/submissions/CIK0001799191.json

Sources and licences

Cite this page

Dragons Eye Ransomware Tracker, "Starling Oncology, Inc.: Form 8-K (Item 1.05) filed with the SEC on 2026-05-22",
entity page, dataset version ref-09468761677a, updated 2026-05-22T20:30:17.000Z,
https://ransomware-tracker.com/breach-notices/us-sec/0001079973-26-000721 (accessed 2026-11-03).
Underlying source: U.S. Securities and Exchange Commission, EDGAR, accession 0001079973-26-000721, filed 2026-05-22.

Pages change. The dataset version identifies the data, but no archive of old versions is kept, so this citation cannot be replayed later.